Ming‐Fu Chang
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- COVID-19 Clinical Research Studies
Papers in
- Hepatology 27
- Hepatitis C virus research 24
- Epidemiology 25
- Hepatitis B Virus Studies 23
- Co-authors
- Miyu Moriyama (1 shared paper)Takeshi Ichinohe (1 shared paper)Shinji Makino (4 shared papers)Sugantha Govindarajan (4 shared papers)Shin C. Chang (11 shared papers)Susan C. Baker (4 shared papers)Michael M. C. Lai (4 shared papers)L H Soe (5 shared papers)
- Journals
- Journal of Virology (19 papers)Journal of Biological Chemistry (7 papers)Virology (5 papers)Journal of Biomedical Science (3 papers)Journal of Bacteriology (2 papers)
- Partner nations
- TaiwanUnited StatesBulgaria
In The Last Decade
Ming‐Fu Chang
72 papers receiving 3.7k citations
Ming‐Fu Chang's Hit Papers
Peers
Comparison fields: 5 of 114
- Hepatology 1.1k
- Infectious Diseases 1.3k
- Animal Science and Zoology 528
- Epidemiology 1.3k
- Virology 164
Countries citing papers authored by Ming‐Fu Chang
This map shows the geographic impact of Ming‐Fu Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Fu Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Fu Chang more than expected).
Fields of papers citing papers by Ming‐Fu Chang
This network shows the impact of papers produced by Ming‐Fu Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Fu Chang. The network helps show where Ming‐Fu Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Fu Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome Hit paper breakdown → | 2019 | 434 |
| 2 | 1987 | 282 | |
| 3 | 1989 | 248 | |
| 4 | 1998 | 212 | |
| 5 | 1988 | 160 | |
| 6 | 2005 | 151 | |
| 7 | 2002 | 134 | |
| 8 | 2016 | 118 | |
| 9 | 1990 | 112 | |
| 10 | 2010 | 97 | |
| 11 | 1989 | 96 | |
| 12 | 1987 | 89 | |
| 13 | 1990 | 84 | |
| 14 | 1998 | 78 | |
| 15 | 2001 | 78 | |
| 16 | 1999 | 74 | |
| 17 | 2020 | 66 | |
| 18 | 2004 | 65 | |
| 19 | 1994 | 62 | |
| 20 | 1989 | 62 |
About Ming‐Fu Chang
Ming‐Fu Chang is a scholar working on Hepatology, Epidemiology, Molecular Biology, Infectious Diseases and Animal Science and Zoology, having authored 73 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (24 papers), Hepatitis B Virus Studies (23 papers), Viral gastroenteritis research and epidemiology (12 papers), Animal Virus Infections Studies (12 papers), SARS-CoV-2 and COVID-19 Research (10 papers), RNA and protein synthesis mechanisms (6 papers), Viral Infections and Immunology Research (6 papers) and Virus-based gene therapy research (5 papers). The work is most often cited by research in Hepatology (1.1k citations), Infectious Diseases (1.3k citations), Animal Science and Zoology (528 citations), Epidemiology (1.3k citations) and Virology (164 citations). Ming‐Fu Chang has collaborated with scholars based in Taiwan, United States and Bulgaria. Frequent co-authors include Miyu Moriyama, Takeshi Ichinohe, Shinji Makino, Sugantha Govindarajan, Shin C. Chang, Susan C. Baker, Michael M. C. Lai, L H Soe, Toshio Kamahora and Arthur Μ. Krieg. Their work appears in journals such as Journal of Virology, Journal of Biological Chemistry, Virology, Journal of Biomedical Science and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.